痕量胺相关受体1配体对大鼠中枢单胺神经元兴奋性的急慢性影响
该研究在大鼠体内采用单细胞电生理技术,观察TAAR1完全激动剂RO5256390和部分激动剂RO5263397对中缝背核5-HT、蓝斑去甲肾上腺素和腹侧被盖区多巴胺神经元兴奋性的急性与慢性作用。结果显示急性RO5256390抑制5-HT和多巴胺神经元,该效应可被RO5263397逆转或预防;慢性RO5256390则增强上述神经元兴奋性,提示TAAR1配体的抗抑郁和抗精神病效应可能部分通过调节中枢5-HT和多巴胺神经元兴奋性介导。
要点
- 急性RO5256390抑制中缝背核5-HT和腹侧被盖区多巴胺神经元兴奋性。
- RO5263397可逆转或预防急性RO5256390对5-HT和多巴胺神经元的抑制。
- 慢性口服RO5256390十四天增强中缝背核5-HT和腹侧被盖区多巴胺神经元兴奋性。
核心结论
- TAAR1配体的潜在抗抑郁和抗精神病效应可能至少部分通过调节中枢5-HT和多巴胺神经元兴奋性介导。
研究设计与样本
- 在麻醉大鼠中采用单细胞电生理记录,评估中缝背核5-HT、蓝斑去甲肾上腺素和腹侧被盖区多巴胺神经元的兴奋性。
- 急性实验静脉给予RO5256390和RO5263397,将给药后神经元兴奋性与同一神经元基础活动比较。
- 慢性实验口服给予RO5256390十四天后进行电生理评估,与溶媒对照大鼠比较神经元兴奋性。
主要发现
- 急性RO5256390抑制5-HT和多巴胺神经元,该效应可被随后给予的RO5263397逆转,也可被提前给予的RO5263397预防。
- 急性RO5256390和RO5263397未以统计学显著方式改变蓝斑去甲肾上腺素神经元兴奋性。
- 慢性RO5256390增强中缝背核5-HT神经元和腹侧被盖区多巴胺神经元的兴奋性。
临床怎么用
- 该临床前电生理证据提示TAAR1配体可能通过调节5-HT和多巴胺神经元兴奋性发挥抗抑郁和抗精神病样行为效应,支持进一步转化研究。
局限性
- 研究在麻醉大鼠体内进行,结果向人类精神心理科临床应用的外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Trace amine-associated receptor 1 (TAAR1) has been recently identified as a target for the future antidepressant, antipsychotic, and anti-addiction drugs. Full (e.g. RO5256390) and partial (e.g. RO5263397) TAAR1 agonists showed antidepressant-, antipsychotic- and anti-addiction-like behavioral effects in rodents and primates. Acute RO5256390 suppressed, and RO5263397 stimulated serotonin (5-HT) neurons of the dorsal raphe nucleus (DRN) and dopamine neurons of the ventral tegmental area (VTA) in brain slices, suggesting that the behavioral effects of TAAR1 ligands involve 5-HT and dopamine. For more comprehensive testing of this hypothesis, we examined acute and chronic effects of RO5256390 and RO5263397 on monoamine neurons in in vivo conditions. Excitability of 5-HT neurons of the DRN, noradrenaline neurons of the locus coeruleus (LC), and dopamine neurons of the VTA was assessed using single-unit electrophysiology in anesthetized rats. For acute experiments, RO5256390 and RO5263397 were administered intravenously; neuronal excitability after RO5256390 and RO5263397 administration was compared to the basal activity of the same neuron. For chronic experiments, RO5256390 was administered orally for fourteen days prior to electrophysiological assessments. The neuronal excitability in RO5256390-treated rats was compared to vehicle-treated controls. We found that acute RO5256390 inhibited 5-HT and dopamine neurons. This effect of RO5256390 was reversed by the subsequent and prevented by the earlier administration of RO5263397. Acute RO5256390 and RO5263397 did not alter the excitability of LC noradrenaline neurons in a statistically significant way. Chronic RO5256390 increased excitability of 5-HT neurons of the DRN and dopamine neurons of the VTA. In conclusion, the putative antidepressant and antipsychotic effects of TAAR1 ligands might be mediated, at least in part, via the modulation of excitability of central 5-HT and dopamine neurons.
引用
- Grinchii D, Hoener MC, Khoury T, et al. Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats. Mol Psychiatry. 2022. PMID: 36045279. doi:10.1038/s41380-022-01739-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。